Page 114 - 南京医科大学学报自然科学版
P. 114
第43卷第10期
·1440 · 南 京 医 科 大 学 学 报 2023年10月
distal regulatory sites characterizes dysregulation of can⁃ NuRD subunit CHD4 regulates super⁃enhancer accessibil⁃
cer genes[J]. Genome Biol,2013,14(3):R21 ity in rhabdomyosarcoma and represents a general tumor
[47] FLEISCHER T,TEKPLI X,MATHELIER A,et al. DNA dependency[J]. Elife,2020,9:e54993
methylation at enhancers identifies distinct breast cancer [60] YI M,TAN Y,WANG L,et al. TP63 links chromatin
lineages[J]. Nat Commun. 2017,8(1):1379 remodeling and enhancer reprogramming to epidermal
[48] YANG L,RODRIGUEZ B,MAYLE A,et al. DNMT3A differentiation and squamous cell carcinoma development
loss drives enhancer hypomethylation in FLT3⁃ITD⁃asso⁃ [J]. Cell Mol Life Sci,2020,77(21):4325-4346
ciated leukemias[J]. Cancer Cell,2016,29(6):922-934 [61] LIU M,DU M,YU J,et al. CEBPA mutants down⁃regulate
[49] XIONG L,WU F,WU Q,et al. Aberrant enhancer hypo⁃ AML cell susceptibility to NK⁃mediated lysis by disrup⁃
methylation contributes to hepatic carcinogenesis through tion of the expression of NKG2D ligands,which can be
global transcriptional reprogramming[J]. Nat Commun, restored by LSD1 inhibition[J]. Oncoimmunology,2022,
2019,10(1):335 11(1):2016158
[50] REYES A A,MARCUM R D,HE Y. Structure and func⁃ [62] RAHNAMOUN H,HONG J,SUN Z,et al. Mutant p53
tion of chromatin remodelers[J]. J Mol Biol,2021,433 regulates enhancer ⁃ associated H3K4 monomethylation
(14):166929 through interactions with the methyltransferase MLL4
[51] ARNAUD O,LE LOARER F,TIRODE F. BAFfling pa⁃ [J]. J Biol Chem,2018,293(34):13234-13246
thologies:alterations of BAF complexes in cancer[J]. [63] RAHNAMOUN H,LEE J,SUN Z,et al. RNAs interact
Cancer Lett,2018,419:266-279 with BRD4 to promote enhanced chromatin engagement
[52] ALVER B H,KIM K H,LU P,et al. The SWI/SNF chro⁃ and transcription activation[J]. Nat Struct Mol Biol,
matin remodelling complex is required for maintenance of 2018,25(8):687-697
lineage specific enhancers[J]. Nat Commun,2017,8: [64] RAHNAMOUN H,LU H,DUTTKE S H,et al. Mutant
14648 p53 shapes the enhancer landscape of cancer cells in re⁃
[53] NAKAYAMA R T,PULICE J L,VALENCIA A M,et al. sponse to chronic immune signaling[J]. Nat Commun,
SMARCB1 is required for widespread BAF complex⁃me⁃ 2017,8(1):754
diated activation of enhancers and bivalent promoters[J]. [65] JOZWIK K M,CHERNUKHIN I,SERANDOUR A A,et
Nat Genet,2017,49(11):1613-1623 al. FOXA1 directs H3K4 monomethylation at enhancers
[54] NAGARAJAN S,RAO S V,SUTTON J,et al. ARID1A in⁃ via recruitment of the methyltransferase MLL3[J]. Cell
fluences HDAC1/BRD4 activity,intrinsic proliferative ca⁃ Rep,2016,17(10):2715-2723
pacity and breast cancer treatment response[J]. Nat Gen⁃ [66] SUN Y,ZHOU B,MAO F,et al. HOXA9 reprograms the
et,2020,52(2):187-197 enhancer landscape to promote leukemogenesis[J]. Can⁃
[55] ST PIERRE R,COLLINGS C K,SAMÉ GUERRA D D,et cer Cell,2018,34(4):643-658
al. SMARCE1 deficiency generates a targetable mSWI/ [67] GRYDER B E,YOHE M E,CHOU H C,et al. PAX3 ⁃
SNF dependency in clear cell meningioma[J]. Nat Genet, FOXO1 establishes myogenic super enhancers and con⁃
2022,54(6):861-873 fers BET bromodomain vulnerability[J]. Cancer Discov,
[56] LAUBSCHER D,GRYDER B E,SUNKEL B D,et al. 2017,7(8):884-899
BAF complexes drive proliferation and block myogenic [68] SKENE P J,HENIKOFF S. An efficient targeted nuclease
differentiation in fusion⁃positive rhabdomyosarcoma[J]. strategy for high⁃resolution mapping of DNA binding sites
Nat Commun,2021,12(1):6924 [J]. Elife,2017,6:e21856
[57] AUGELLO M A,LIU D,DEONARINE L D,et al. CHD1 [69] HO S W T,SHENG T,XING M,et al. Regulatory enhan⁃
loss alters AR binding at lineage⁃specific enhancers and cer profiling of mesenchymal⁃type gastric cancer reveals
modulates distinct transcriptional programs to drive pro⁃ subtype ⁃ specific epigenomic landscapes and targetable
state tumorigenesis[J]. Cancer Cell,2019,35(4):603- vulnerabilities[J]. Gut,2023,72(2):226-241
617 [70] ARNOLD C D,GERLACH D,STELZER C,et al. Genome⁃
[58] MENON T,YATES J A,BOCHAR D A. Regulation of an⁃ wide quantitative enhancer activity maps identified by
drogen⁃responsive transcription by the chromatin remodel⁃ STARR⁃seq[J]. Science,2013,339(6123):1074-1077
ing factor CHD8[J]. Mol Endocrinol,2010,24(6):1165- [71] WANG Y,LI J,LI J,et al. An enhancer⁃based analysis
1174 revealed a new function of androgen receptor in tumor
[59] MARQUES J G,GRYDER B E,PAVLOVIC B,et al. (下转第1478页)